It's Official: House Approves Bill To Further Expand Medical Marijuana Research

The House of Representatives passed the Medical Marijuana Research Act, which will substantially expand scientific research on marijuana, including allowing scientists to study products from dispensaries. 

Filed by Rep. Earl Blumenauer [D-OR] and Rep. Andy Harris [R-MD], the bill will ease the process by which researchers apply for approval to study cannabis and will place deadlines on federal agencies to consider the applications in a timely manner.

Advocates Respond

“Cannabis has a wide range of therapeutic applications, but researchers have consistently faced significant roadblocks to conducting studies. Research is key to evaluating and unlocking the full potential of cannabis, and we applaud the House for passing legislation that would greatly expand the eligible supply of cannabis for studies," said US Cannabis Council CEO Steven Hawkins.

What Does The Bill Do?

The bill will streamline the licensure process for researchers seeking to conduct cannabis research and will facilitate access to an increased supply of higher-quality medical-grade cannabis for study purposes. It will also ensure that research on cannabis and other potentially beneficial marijuana-derived substances is based on sound science by reducing the regulatory barriers associated with marijuana research.

“Today’s House vote and last month’s unanimous Senate vote on a more limited proposal both strongly signal that Congress is committed to cannabis research. We urge House and Senate leaders to consolidate their bills and pass meaningful cannabis research reform this year,” added Hawkins.

Senate-Approved Bipartisan Marijuana Research Bill

The latest breakthrough in cannabis federal reform comes on the heels of the Senate unanimously passing a different cannabis research bill sponsored by Sens. Dianne Feinstein (D-CA), Brian Schatz (D-HI), and Chuck Grassley (R-IA), and called the Cannabidiol and Marihuana Research Expansion Act. It was approved unanimously, without debate, after being reintroduced in February 2021. 

Photo: Courtesy of National Cancer Institute on Unsplash


Posted In: cannabis research billEarl BlumenauerHouse of RepresentativesmarijuanaCannabisGovernmentNewsRegulationsPoliticsMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.